Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2025-12-25 @ 5:26 PM
Study NCT ID:
NCT02903004
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2016-08-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS